Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., PhD., President and Chief Executive Officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10th at 2:15 pm PT / 5:15 pm ET.
Related news for (IRON)
- Power Hour Pulse: From Helium Hype to Quantum Defense — Stocks to Watch into the Close
- Morning Movers & Moonshots: VirnetX Rockets, Carbon Revolution Accelerates, and Disc Medicine Grabs FDA’s Fast Track
- Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
- Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
- Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress